La Jolla Labs
Melissa Keenan is a consulting blog writer at La Jolla Labs. Melissa has previously worked as a postdoctoral scientist at Ionis Pharmaceuticals, Inc., developing in vitro model systems to apply the company's antisense oligonucleotide therapeutics platform to discovering treatments for Cystic Fibrosis. Keenan was also a graduate student at Duke University Medical Center, conducting a genome-wide screen to investigate the genes cancer cells require for survival under tumor microenvironment stresses such as hypoxia and lactic acidosis. Before that, they worked as a lab assistant at Celgene and Harris Moran Seed Company, and as a cell biology intern at UC Davis.
Melissa M. Keenan has a Doctor of Philosophy (Ph.D.) from Duke University in the field of Certificates in College Teaching, Genetics & Genomics and Cell & Molecular biology. Melissa also has a Bachelor of Science (B.S.) cum laude in Molecular Biology from UC San Diego. In addition, they have non-degree granting professional education from Coursera (Online Education Platform) in various fields of study.
Their manager is Jeff Milton, CEO. Melissa M. Keenan works with Mitch Ledwith - Bioinformatics Scientist, Geramie Grande Shaver - Scientist, and Kendra Keating - Director, Operations.
This person is not in any offices
La Jolla Labs
La Jolla Labs is privately held therapeutics company with research in high-throughput screening technology for drug discovery.